Ignite Creation Date:
2025-12-24 @ 2:50 PM
Ignite Modification Date:
2026-07-18 @ 11:32 PM
Study NCT ID:
NCT01729559
Status:
COMPLETED
Last Update Posted:
2016-07-18
First Post:
2012-11-14
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Venous Thromboembolic Prophylaxis After Trauma: Three Times a Day Unfractionated Heparin Versus Twice a Day Enoxaparin
Sponsor:
Scripps Health
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
IRB-12-5973
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None